What Does Sperm Morphology Actually Tell You? An Honest Look at the Research

Part 3 of the SwimScore Fertility Series: Morphology

Of all the parameters in a semen analysis, morphology is the one we get the most questions about. It's also the one where we think the popular narrative diverges most from what the science actually shows. Men see a number below 4% and panic. Clinics use it to recommend IVF. Supplement brands market products to fix it.

The reality is more nuanced — and in some ways, more reassuring — than most of what you'll read. Here's what the research actually shows, what morphology does and doesn't tell you, and where we land practically.

What Sperm Morphology Is

Morphology is the measurement of sperm shape. Under a microscope, trained technicians classify each sperm as normal or abnormal based on the appearance of the head, midpiece, and tail. A normal sperm has a smooth, oval head of specific dimensions, an intact midpiece, and a single uncoiled tail. Abnormalities in any of these structures classify a sperm as morphologically abnormal.

The WHO 6th Edition sets the reference threshold at 4% — meaning at least 4% of sperm in a sample should have normal morphology. This figure is known as Kruger strict criteria, one of the most stringent classification systems available. It was developed by examining sperm that had successfully migrated to the upper cervical canal after natural intercourse — theoretically representing the highest-performing sperm.

Here is something worth knowing before interpreting your number: the WHO threshold for normal morphology has changed five times since 1980. It started at 80.5%, dropped to 50%, then 30%, then 14%, and is now 4%. (NIH PMC, 2024) This is not a minor revision. It reflects genuine scientific uncertainty about where the clinically meaningful threshold actually lies, and it means the number you're being judged against today would have classified nearly every man as abnormal under criteria used 40 years ago.

What the Research Shows About Morphology and Fertility

This is where morphology gets genuinely interesting — and where we think the field has overcorrected in both directions.

The early morphology research, primarily from the 1980s and 1990s, found meaningful associations between normal morphology and IVF fertilization rates. The landmark Kruger studies showed fertilization rates of 59.3% versus 77.6% for men below and above 4% normal forms respectively. (Kruger et al., as cited in Pelzman et al., Reproductive Medicine and Biology, 2024) These findings established morphology as an important clinical parameter and drove its inclusion in routine semen analysis.

More recent research paints a different picture. A 2024 review published in Reproductive Medicine and Biology — one of the most comprehensive assessments of morphology's clinical utility — found that most recent studies fail to show an association between sperm morphology and natural or assisted fertility outcomes, concluding that morphology analysis may have limited diagnostic and prognostic value. (Pelzman et al., Reproductive Medicine and Biology, 2024)

Some of the specific findings are striking. A systematic review and meta-analysis of 20 observational trials found no clinical or statistical difference in pregnancy rates per intrauterine insemination when comparing men above and below the 4% threshold — including at a 1% threshold. (as cited in Fertility and Sterility Reports, 2021) In couples proceeding to IVF with ICSI, multiple studies found no difference in fertilization rates, pregnancy rates, or implantation rates based on morphology. (Svalander et al., as cited in Pelzman et al., 2024) Perhaps most strikingly, even men with 0% normal forms — complete teratozoospermia — have been reported to achieve pregnancy rates of 39% per cycle without assisted reproduction, and 29.2% of men with zero normal forms in one study did not require ART for their first pregnancy. (Kovac et al., as cited in Fertility and Sterility Reports, 2021)

One important reason for these confusing findings is measurement. Morphology assessment is subjective and highly variable between labs and technicians. The same sample assessed by different trained analysts can produce meaningfully different results. A study noted that 90.9% of semen analyses were classified as abnormal under WHO 4th edition criteria — and that 35.9% of those abnormal results became normal under 5th edition strict criteria applied to the same samples. (Fertility and Sterility Reports, 2021) When a parameter produces results that vary this much based on who reads the slide and which criteria they use, its clinical utility as a standalone predictor is genuinely limited.

The American Urological Association's Best Practice statement reflects this: sperm morphology by Kruger strict criteria was not shown to be a predictive indicator of fertility, and its use in isolation to make clinical management decisions was not recommended. (as cited in Fertility and Sterility Reports, 2021)

So Does Morphology Matter at All?

Yes — but with important caveats that most labs and clinics don't communicate clearly.

Morphology matters most in combination with other parameters, not in isolation. A man with low morphology alongside low count and low progressive motility is in a different situation than a man with low morphology and normal count and motility. Studies consistently show that when controlling for other semen parameters, morphology's independent association with fertility outcomes weakens or disappears. (Pelzman et al., Reproductive Medicine and Biology, 2024)

Morphology also matters at the extremes. Men with very severe teratozoospermia — consistently below 1% or 0% normal forms — do face more significant fertility challenges, though even here the outcomes are better than the number suggests.

It also serves as a flag for underlying conditions. Specific patterns of morphological abnormality point toward identifiable problems: abnormal head forms can indicate DNA packaging issues or oxidative stress; midpiece defects suggest mitochondrial dysfunction relevant to motility; tail defects point toward structural problems in sperm development. In this sense, morphology is more useful as a diagnostic clue than as a standalone fertility predictor.

And morphology may be more predictive in conventional IVF than in ICSI. In conventional IVF, sperm must still select and penetrate the egg — a process where shape matters. In ICSI, the embryologist selects and injects a sperm directly, bypassing the need for natural selection, which reduces morphology's relevance to the outcome considerably.

What Causes Poor Morphology

Unlike progressive motility, which is primarily driven by oxidative stress and mitochondrial function, poor morphology has multiple distinct origins — and some are more addressable than others.

Oxidative stress damages sperm during development, producing abnormal head shapes, midpiece defects, and tail abnormalities. This is the pathway most responsive to antioxidant supplementation.

Varicocele is associated with significantly elevated rates of morphological abnormalities, driven by the same heat and oxidative stress mechanisms that impair other parameters. Varicocele repair improves morphology alongside other parameters.

Genetic factors play a role in some cases of severe teratozoospermia. Certain gene mutations affect the structural proteins required for normal sperm development. These are not addressable through supplementation.

Heat exposure impairs the tightly regulated process of sperm development in the testes, producing higher rates of malformed sperm. Laptops on the lap, frequent saunas, and occupational heat exposure all contribute.

Infection and inflammation in the reproductive tract elevate reactive oxygen species locally and disrupt normal sperm maturation.

Age is an underappreciated factor. Morphology declines meaningfully with paternal age as DNA repair mechanisms in the testes deteriorate and oxidative damage accumulates over time.

What the Research Shows on Supplements

The supplement evidence for morphology is thinner and less consistent than for progressive motility or DNA fragmentation. Here is what we actually found.

Alpha-lipoic acid has the most specific evidence for morphology among all supplements studied. A 2024 systematic review and meta-analysis of five randomized controlled trials found that alpha-lipoic acid supplementation produced a statistically significant reduction in abnormal morphology alongside improvements in total and progressive motility. (PMC, 2024) The Henriksen 2025 meta-analysis — which we've referenced throughout this series — similarly found that alpha-lipoic acid was the only supplement to significantly improve normal morphology in its rigorous analysis of placebo-controlled trials. (Henriksen et al., Nutrients, 2025) The mechanism is relevant: alpha-lipoic acid is both water and fat soluble, allowing it to penetrate cell membranes and mitochondria where oxidative damage to developing sperm occurs.

L-carnitine shows some morphology benefits in individual studies. One RCT comparing L-carnitine against CoQ10 and vitamin E found significant improvements in morphology in both groups compared to baseline. (European Review for Medical and Pharmacological Sciences, 2022) A study of L-carnitine in men with teratozoospermia found significant reductions in head defects specifically, which the authors attributed to carnitine's role in protecting sperm DNA and membranes from oxidative damage. (ScienceDirect, 2010) However, the meta-analysis evidence for carnitine and morphology is less consistent than for motility.

Selenium and CoQ10 show some individual trial improvements in morphology, but the evidence across rigorous placebo-controlled trials is mixed. The Henriksen analysis found neither selenium nor CoQ10 reached statistical significance for morphology improvement in its primary analyses.

Multi-supplement combinations show the most consistent morphology improvements across trials, which again makes biological sense — if oxidative stress during sperm development is the primary driver, targeting it from multiple angles simultaneously produces better results than any single compound.

We're more skeptical of morphology-specific supplement claims than for any other parameter in this series. The evidence is thinner, the baseline clinical significance of morphology as an isolated finding is genuinely debated, and the measurement variability between labs means the number you're trying to improve may not be as reliable a target as it appears.

The Pregnancy Question

Consistent with what we've said throughout this series: we know certain supplements improve measured morphology in some trials. Whether that improvement translates to better pregnancy outcomes hasn't been demonstrated. For morphology specifically, this gap is even more pronounced — because the direct link between morphology scores and pregnancy outcomes is itself contested in the literature.

What we do believe is that the oxidative stress environment that produces poor morphology also damages other parameters simultaneously. Treating oxidative stress is therefore not just about morphology — it improves the broader sperm quality picture. A man with poor morphology driven by oxidative stress is likely to have concurrent issues with DNA fragmentation and possibly motility. Addressing the underlying environment may improve all three, even if morphology alone is a blunt outcome measure.

How to Think About This Practically

Don't panic about a number below 4% in isolation. If your count and progressive motility are normal and your morphology is low, the research suggests this is the least concerning pattern. Most men with isolated low morphology and normal other parameters conceive without intervention.

Take it more seriously in combination. Low morphology alongside low progressive motility and low count — the triad known as oligoasthenoteratozoospermia, or OAT — is a more meaningful finding that warrants proper clinical investigation.

Consider what's driving it. If you have a confirmed varicocele, that's the starting point — not supplementation. If the cause is primarily oxidative stress or lifestyle factors, addressing those makes more sense than focusing narrowly on a morphology number.

If you supplement for morphology, alpha-lipoic acid has the most specific evidence. It's the only supplement to show consistent morphology improvement in the rigorous Henriksen analysis and in its own dedicated meta-analysis. L-carnitine is a reasonable addition given its broader antioxidant role. We wouldn't lead with CoQ10 specifically for morphology, though its benefits for motility and DNA fragmentation make it worthwhile for the overall sperm quality picture.

Be aware of lab variability. If your morphology result concerns you, it's worth understanding which criteria your lab used, and knowing that results can differ meaningfully between labs even on the same sample. A single morphology reading is a data point, not a diagnosis.

Measure before. Measure after. The same principle applies here as throughout this series. If you make changes, give it at least 12 weeks and retest. Without a before and after, you're guessing.

Our Take

Morphology is the most contested parameter in male fertility assessment. The research that established it as clinically important came mostly from the 1980s and 1990s. More recent, better-designed studies consistently fail to find an independent association between morphology scores and natural or assisted conception outcomes. The American Urological Association explicitly advises against using it in isolation to make clinical decisions.

That doesn't mean it's meaningless. Severe teratozoospermia is a real finding. Specific morphological patterns point toward underlying conditions worth investigating. And the oxidative stress environment that drives poor morphology affects other parameters too. But an isolated low morphology result — particularly one that sits just below 4% with otherwise normal parameters — should not be interpreted as a fertility sentence. The research does not support that reading.

We know certain supplements, particularly alpha-lipoic acid, improve measured morphology. Whether that improvement changes fertility outcomes isn't established. What we believe is that treating the oxidative environment that causes poor morphology is worthwhile for the broader sperm quality picture — not because morphology alone is the critical number, but because it rarely travels alone.

This is Part 3 of the SwimScore Fertility Series. Next up: Sperm Concentration.

SwimScore uses CLIA-certified labs for all semen analysis and hormone testing, assessed against WHO 6th Edition clinical thresholds.

See our part 1 article on progressive motility and part 2 article on DNA fragmentation